+1 347 708 0418
The Active Pharmaceutical Ingredient (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Active Pharmaceutical Ingredient (API) size is estimated to be xx million in 2021 from USD 65040 million in 2020, with a change of XX% between 2020 and 2021. The global Active Pharmaceutical Ingredient (API) market size is expected to grow at a CAGR of 6.3% for the next five years.
Market segmentation
Active Pharmaceutical Ingredient (API) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Anti-Infective
Hormonal
Others
Market segment by Application can be divided into
Respiratory
Rheumatology
Diabetes
Oncology
Others
The key market players for global Active Pharmaceutical Ingredient (API) market are listed below:
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddys Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Active Pharmaceutical Ingredient (API) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Active Pharmaceutical Ingredient (API), with price, sales, revenue and global market share of Active Pharmaceutical Ingredient (API) from 2019 to 2021.
Chapter 3, the Active Pharmaceutical Ingredient (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Active Pharmaceutical Ingredient (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Active Pharmaceutical Ingredient (API) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Active Pharmaceutical Ingredient (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Active Pharmaceutical Ingredient (API) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Active Pharmaceutical Ingredient (API) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Anti-Infective
1.2.3 Hormonal
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Active Pharmaceutical Ingredient (API) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Respiratory
1.3.3 Rheumatology
1.3.4 Diabetes
1.3.5 Oncology
1.3.6 Others
1.4 Global Active Pharmaceutical Ingredient (API) Market Size & Forecast
1.4.1 Global Active Pharmaceutical Ingredient (API) Sales in Value (2016-2026))
1.4.2 Global Active Pharmaceutical Ingredient (API) Sales in Volume (2016-2026)
1.4.3 Global Active Pharmaceutical Ingredient (API) Price by Type (2016-2026) & (USD/Unit)
1.5 Global Active Pharmaceutical Ingredient (API) Production Capacity Analysis
1.5.1 Global Active Pharmaceutical Ingredient (API) Total Production Capacity (2016-2026)
1.5.2 Global Active Pharmaceutical Ingredient (API) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Active Pharmaceutical Ingredient (API) Market Drivers
1.6.2 Active Pharmaceutical Ingredient (API) Market Restraints
1.6.3 Active Pharmaceutical Ingredient (API) Trends Analysis
2 Manufacturers Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Active Pharmaceutical Ingredient (API) Product and Services
2.1.4 Teva Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Active Pharmaceutical Ingredient (API) Product and Services
2.2.4 Mylan Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 DSM
2.3.1 DSM Details
2.3.2 DSM Major Business
2.3.3 DSM Active Pharmaceutical Ingredient (API) Product and Services
2.3.4 DSM Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Aurobindo Pharma
2.4.1 Aurobindo Pharma Details
2.4.2 Aurobindo Pharma Major Business
2.4.3 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product and Services
2.4.4 Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Active Pharmaceutical Ingredient (API) Product and Services
2.5.4 Aspen Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Active Pharmaceutical Ingredient (API) Product and Services
2.6.4 Novartis Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 BASF
2.7.1 BASF Details
2.7.2 BASF Major Business
2.7.3 BASF Active Pharmaceutical Ingredient (API) Product and Services
2.7.4 BASF Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Active Pharmaceutical Ingredient (API) Product and Services
2.8.4 Pfizer Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Huahai Pharmaceutical
2.9.1 Huahai Pharmaceutical Details
2.9.2 Huahai Pharmaceutical Major Business
2.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
2.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Hisun Pharmaceutical
2.10.1 Hisun Pharmaceutical Details
2.10.2 Hisun Pharmaceutical Major Business
2.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
2.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business
2.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product and Services
2.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Zhejiang Medicine
2.12.1 Zhejiang Medicine Details
2.12.2 Zhejiang Medicine Major Business
2.12.3 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product and Services
2.12.4 Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Dr. Reddys Laboratories
2.13.1 Dr. Reddys Laboratories Details
2.13.2 Dr. Reddys Laboratories Major Business
2.13.3 Dr. Reddys Laboratories Active Pharmaceutical Ingredient (API) Product and Services
2.13.4 Dr. Reddys Laboratories Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Zhejiang NHU
2.14.1 Zhejiang NHU Details
2.14.2 Zhejiang NHU Major Business
2.14.3 Zhejiang NHU Active Pharmaceutical Ingredient (API) Product and Services
2.14.4 Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Active Pharmaceutical Ingredient (API) Product and Services
2.15.4 Bayer Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 NCPC
2.16.1 NCPC Details
2.16.2 NCPC Major Business
2.16.3 NCPC Active Pharmaceutical Ingredient (API) Product and Services
2.16.4 NCPC Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 AbbVie
2.17.1 AbbVie Details
2.17.2 AbbVie Major Business
2.17.3 AbbVie Active Pharmaceutical Ingredient (API) Product and Services
2.17.4 AbbVie Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Shandong Xinhua Pharmaceutical
2.18.1 Shandong Xinhua Pharmaceutical Details
2.18.2 Shandong Xinhua Pharmaceutical Major Business
2.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
2.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Northeast Pharm
2.19.1 Northeast Pharm Details
2.19.2 Northeast Pharm Major Business
2.19.3 Northeast Pharm Active Pharmaceutical Ingredient (API) Product and Services
2.19.4 Northeast Pharm Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Harbin Pharmaceutical
2.20.1 Harbin Pharmaceutical Details
2.20.2 Harbin Pharmaceutical Major Business
2.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
2.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 LKPC
2.21.1 LKPC Details
2.21.2 LKPC Major Business
2.21.3 LKPC Active Pharmaceutical Ingredient (API) Product and Services
2.21.4 LKPC Active Pharmaceutical Ingredient (API) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Active Pharmaceutical Ingredient (API) Sales by Manufacturer
3.1 Global Active Pharmaceutical Ingredient (API) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Active Pharmaceutical Ingredient (API) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Active Pharmaceutical Ingredient (API)
3.4 Market Concentration Rate
3.4.1 Top 3 Active Pharmaceutical Ingredient (API) Manufacturer Market Share
3.4.2 Top 6 Active Pharmaceutical Ingredient (API) Manufacturer Market Share
3.5 Global Active Pharmaceutical Ingredient (API) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Active Pharmaceutical Ingredient (API) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Active Pharmaceutical Ingredient (API) Market Size by Region
4.1.1 Global Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2016-2026)
4.1.2 Global Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2026)
4.2 North America Active Pharmaceutical Ingredient (API) Revenue (2016-2026)
4.3 Europe Active Pharmaceutical Ingredient (API) Revenue (2016-2026)
4.4 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (2016-2026)
4.5 South America Active Pharmaceutical Ingredient (API) Revenue (2016-2026)
4.6 Middle East and Africa Active Pharmaceutical Ingredient (API) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Active Pharmaceutical Ingredient (API) Sales in Volume by Type (2016-2026)
5.2 Global Active Pharmaceutical Ingredient (API) Revenue by Type (2016-2026)
5.3 Global Active Pharmaceutical Ingredient (API) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Active Pharmaceutical Ingredient (API) Sales in Volume by Application (2016-2026)
6.2 Global Active Pharmaceutical Ingredient (API) Revenue by Application (2016-2026)
6.3 Global Active Pharmaceutical Ingredient (API) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Active Pharmaceutical Ingredient (API) Sales by Type (2016-2026)
7.2 North America Active Pharmaceutical Ingredient (API) Sales by Application (2016-2026)
7.3 North America Active Pharmaceutical Ingredient (API) Market Size by Country
7.3.1 North America Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2016-2026)
7.3.2 North America Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Active Pharmaceutical Ingredient (API) Sales by Type (2016-2026)
8.2 Europe Active Pharmaceutical Ingredient (API) Sales by Application (2016-2026)
8.3 Europe Active Pharmaceutical Ingredient (API) Market Size by Country
8.3.1 Europe Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2016-2026)
8.3.2 Europe Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Type (2016-2026)
9.2 Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Application (2016-2026)
9.3 Asia-Pacific Active Pharmaceutical Ingredient (API) Market Size by Region
9.3.1 Asia-Pacific Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Active Pharmaceutical Ingredient (API) Sales by Type (2016-2026)
10.2 South America Active Pharmaceutical Ingredient (API) Sales by Application (2016-2026)
10.3 South America Active Pharmaceutical Ingredient (API) Market Size by Country
10.3.1 South America Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2016-2026)
10.3.2 South America Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Type (2016-2026)
11.2 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Application (2016-2026)
11.3 Middle East & Africa Active Pharmaceutical Ingredient (API) Market Size by Country
11.3.1 Middle East & Africa Active Pharmaceutical Ingredient (API) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Active Pharmaceutical Ingredient (API) Typical Distributors
12.3 Active Pharmaceutical Ingredient (API) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Active Pharmaceutical Ingredient (API) Revenue by Type, (USD Million), 2021-2026
Table 2. Global Active Pharmaceutical Ingredient (API) Revenue by Application, (USD Million), 2021-2026
Table 3. Teva Basic Information, Manufacturing Base and Competitors
Table 4. Teva Major Business
Table 5. Teva Active Pharmaceutical Ingredient (API) Product and Services
Table 6. Teva Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Active Pharmaceutical Ingredient (API) Product and Services
Table 10. Mylan Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. DSM Basic Information, Manufacturing Base and Competitors
Table 12. DSM Major Business
Table 13. DSM Active Pharmaceutical Ingredient (API) Product and Services
Table 14. DSM Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Aurobindo Pharma Major Business
Table 17. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Product and Services
Table 18. Aurobindo Pharma Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aspen Basic Information, Manufacturing Base and Competitors
Table 20. Aspen Major Business
Table 21. Aspen Active Pharmaceutical Ingredient (API) Product and Services
Table 22. Aspen Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Major Business
Table 25. Novartis Active Pharmaceutical Ingredient (API) Product and Services
Table 26. Novartis Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. BASF Basic Information, Manufacturing Base and Competitors
Table 28. BASF Major Business
Table 29. BASF Active Pharmaceutical Ingredient (API) Product and Services
Table 30. BASF Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Major Business
Table 33. Pfizer Active Pharmaceutical Ingredient (API) Product and Services
Table 34. Pfizer Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Huahai Pharmaceutical Major Business
Table 37. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
Table 38. Huahai Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Hisun Pharmaceutical Major Business
Table 41. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
Table 42. Hisun Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries Major Business
Table 45. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Product and Services
Table 46. Sun Pharmaceutical Industries Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Medicine Major Business
Table 49. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Product and Services
Table 50. Zhejiang Medicine Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 52. Dr. Reddys Laboratories Major Business
Table 53. Dr. Reddys Laboratories Active Pharmaceutical Ingredient (API) Product and Services
Table 54. Dr. Reddys Laboratories Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Zhejiang NHU Basic Information, Manufacturing Base and Competitors
Table 56. Zhejiang NHU Major Business
Table 57. Zhejiang NHU Active Pharmaceutical Ingredient (API) Product and Services
Table 58. Zhejiang NHU Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Active Pharmaceutical Ingredient (API) Product and Services
Table 62. Bayer Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. NCPC Basic Information, Manufacturing Base and Competitors
Table 64. NCPC Major Business
Table 65. NCPC Active Pharmaceutical Ingredient (API) Product and Services
Table 66. NCPC Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. AbbVie Basic Information, Manufacturing Base and Competitors
Table 68. AbbVie Major Business
Table 69. AbbVie Active Pharmaceutical Ingredient (API) Product and Services
Table 70. AbbVie Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Shandong Xinhua Pharmaceutical Major Business
Table 73. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
Table 74. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Northeast Pharm Basic Information, Manufacturing Base and Competitors
Table 76. Northeast Pharm Major Business
Table 77. Northeast Pharm Active Pharmaceutical Ingredient (API) Product and Services
Table 78. Northeast Pharm Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Harbin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Harbin Pharmaceutical Major Business
Table 81. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Product and Services
Table 82. Harbin Pharmaceutical Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. LKPC Basic Information, Manufacturing Base and Competitors
Table 84. LKPC Major Business
Table 85. LKPC Active Pharmaceutical Ingredient (API) Product and Services
Table 86. LKPC Active Pharmaceutical Ingredient (API) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Global Active Pharmaceutical Ingredient (API) Sales by Manufacturer (2019-2021e) & (K Units)
Table 88. Global Active Pharmaceutical Ingredient (API) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 89. Market Position of Manufacturers in Active Pharmaceutical Ingredient (API), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 90. Global Active Pharmaceutical Ingredient (API) Production Capacity by Company, (K Units): 2020 VS 2021
Table 91. Head Office and Active Pharmaceutical Ingredient (API) Production Site of Key Manufacturer
Table 92. Active Pharmaceutical Ingredient (API) New Entrant and Capacity Expansion Plans
Table 93. Active Pharmaceutical Ingredient (API) Mergers & Acquisitions in the Past Five Years
Table 94. Global Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021e) & (K Units)
Table 95. Global Active Pharmaceutical Ingredient (API) Sales by Region (2021-2026) & (K Units)
Table 96. Global Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021e) & (USD Million)
Table 97. Global Active Pharmaceutical Ingredient (API) Revenue by Region (2021-2026) & (USD Million)
Table 98. Global Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 99. Global Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 100. Global Active Pharmaceutical Ingredient (API) Revenue by Type (2016-2021e) & (USD Million)
Table 101. Global Active Pharmaceutical Ingredient (API) Revenue by Type (2021-2026) & (USD Million)
Table 102. Global Active Pharmaceutical Ingredient (API) Price by Type (2016-2021e) & (USD/Unit)
Table 103. Global Active Pharmaceutical Ingredient (API) Price by Type (2021-2026) & (USD/Unit)
Table 104. Global Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 105. Global Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 106. Global Active Pharmaceutical Ingredient (API) Revenue by Application (2016-2021e) & (USD Million)
Table 107. Global Active Pharmaceutical Ingredient (API) Revenue by Application (2021-2026) & (USD Million)
Table 108. Global Active Pharmaceutical Ingredient (API) Price by Application (2016-2021e) & (USD/Unit)
Table 109. Global Active Pharmaceutical Ingredient (API) Price by Application (2021-2026) & (USD/Unit)
Table 110. North America Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021e) & (K Units)
Table 111. North America Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (K Units)
Table 112. North America Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021e) & (USD Million)
Table 113. North America Active Pharmaceutical Ingredient (API) Revenue by Country (2021-2026) & (USD Million)
Table 114. North America Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 115. North America Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 116. North America Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 117. North America Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 118. Europe Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021e) & (K Units)
Table 119. Europe Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (K Units)
Table 120. Europe Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021e) & (USD Million)
Table 121. Europe Active Pharmaceutical Ingredient (API) Revenue by Country (2021-2026) & (USD Million)
Table 122. Europe Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 123. Europe Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 124. Europe Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 125. Europe Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 126. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021e) & (K Units)
Table 127. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Region (2021-2026) & (K Units)
Table 128. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021e) & (USD Million)
Table 129. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue by Region (2021-2026) & (USD Million)
Table 130. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 131. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 132. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 133. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 134. South America Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021e) & (K Units)
Table 135. South America Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (K Units)
Table 136. South America Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021e) & (USD Million)
Table 137. South America Active Pharmaceutical Ingredient (API) Revenue by Country (2021-2026) & (USD Million)
Table 138. South America Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 139. South America Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 140. South America Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 141. South America Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 142. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021e) & (K Units)
Table 143. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (K Units)
Table 144. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021e) & (USD Million)
Table 145. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue by Country (2021-2026) & (USD Million)
Table 146. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Type (2016-2021e) & (K Units)
Table 147. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (K Units)
Table 148. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Application (2016-2021e) & (K Units)
Table 149. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (K Units)
Table 150. Direct Channel Pros & Cons
Table 151. Indirect Channel Pros & Cons
Table 152. Active Pharmaceutical Ingredient (API) Typical Distributors
Table 153. Active Pharmaceutical Ingredient (API) Typical Customers
List of Figures
Figure 1. Active Pharmaceutical Ingredient (API) Picture
Figure 2. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Type in 2020
Figure 3. Anti-Infective
Figure 4. Hormonal
Figure 5. Others
Figure 6. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Application in 2020
Figure 7. Respiratory
Figure 8. Rheumatology
Figure 9. Diabetes
Figure 10. Oncology
Figure 11. Others
Figure 12. Global Active Pharmaceutical Ingredient (API) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Active Pharmaceutical Ingredient (API) Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Active Pharmaceutical Ingredient (API) Sales (2016-2026) & (K Units)
Figure 15. Global Active Pharmaceutical Ingredient (API) Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global Active Pharmaceutical Ingredient (API) Production Capacity (2016-2026) & (K Units)
Figure 17. Global Active Pharmaceutical Ingredient (API) Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Active Pharmaceutical Ingredient (API) Market Drivers
Figure 19. Active Pharmaceutical Ingredient (API) Market Restraints
Figure 20. Active Pharmaceutical Ingredient (API) Market Trends
Figure 21. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturer in 2020
Figure 22. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturer in 2020
Figure 23. Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Active Pharmaceutical Ingredient (API) Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Active Pharmaceutical Ingredient (API) Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2026)
Figure 27. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2026)
Figure 28. North America Active Pharmaceutical Ingredient (API) Revenue (2016-2026) & (USD Million)
Figure 29. Europe Active Pharmaceutical Ingredient (API) Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue (2016-2026) & (USD Million)
Figure 31. South America Active Pharmaceutical Ingredient (API) Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue (2016-2026) & (USD Million)
Figure 33. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2026)
Figure 34. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2026)
Figure 35. Global Active Pharmaceutical Ingredient (API) Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 37. Global Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2016-2026)
Figure 38. Global Active Pharmaceutical Ingredient (API) Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2026)
Figure 40. North America Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 41. North America Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2026)
Figure 42. North America Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2026)
Figure 43. United States Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2026)
Figure 47. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 48. Europe Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2026)
Figure 49. Europe Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2026)
Figure 50. Germany Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2026)
Figure 59. China Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2026)
Figure 66. South America Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 67. South America Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2026)
Figure 68. South America Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Active Pharmaceutical Ingredient (API) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Buy
